rhesus monkeys with chronic Plasmodium knowlesi infections conferred a passive immunity upon normal monkeys. Mosna (2) in 1938 repeated the work with essentially the same results. Hegner and Eskridge (3), using the concentrated serum of canaries immune to Plasmodium cathemerium, attempted to produce a passive immunity in normal birds and concluded that an alleviation of symptoms resulted although no diminution of the intensity of infections was noted. Manwell and Goldstein (4) conclusively demonstrated the inhibitory effect of immune serum on Plasmodium circumflexum infections when used in a protection test. More recently Taliaferro and Taliaferro (5) have shown that the intensity of Plasmodium Iophurae infections in chicks can be diminished by homologous immune serum administered daily throughout the course of the acute infection, and that incubation of immune serum and parasitized red cells at 37°C. for 2 hours greatly enhanced the protective action of the immune serum.
Unfortunately, there remain difficulties in testing the protective property of human serum in experimental animals by the methods used in the studies mentioned above. In the first place, the plasmodia which naturally infect man are not known to be pathogenic for any lower vertebrate host and, therefore, are not readily adaptable for use in protection tests. Secondly, the lack of available non-immune volunteers or paretics who could be inoculated with malaria under controlled conditions presents almost insurmountable difficulties in a protection test confined solely to human beings. Finally, the great amount of immune serum necessary to demonstrate a definite protective effect in monkeys on the basis of body weight would 21 eliminate the repetition of the experiment in man, assuming t h a t the proportions were similar in b o t h instances. However, a m e t h o d for extending the s t u d y of humoral i m m u n i t y to malaria in m a n was suggested b y the work of Knowles and D a s G u p t a (6) who succeeded in producing an infection with P. knowlesi in three h u m a n volunteers. T h u s serum obtained from patients with induced knowlesi malaria could be tested for protective antibodies in rhesus monkeys. T h e same specimens could also be tested for the presence of agglutinins and complement-fixing antibodies. Accordingly, experiments were made using serum from patients with induced knowlesi malaria in an a t t e m p t to d e m o n s t r a t e the existence of humoral i m m u n e substances.
Methods
The source of the serum was one Negro patient at the New York HospitaP and six Negro patients at the Manhattan State Hospital, 1 all suffering from general paresis. Two had previously been found resistant to infection with vivax malaria when inoculated for therapeutic purposes. The patients were bled for serum and then inoculated intravenously or intramuscularly with 1 to 5 cc. of citrated blood from a rhesus monkey after tests showed that the animal was suffering from no infection other than P. knowlesi malaria. The patients were then bled at various intervals after recovery from the acute attack.
Protection Tests.--The protection tests with human serum were done by the method of Coggeshall and Kumm (7) with certain modifications aimed at increasing the sensitivity of the test. These modifications were the result of a previous study by Coggeshall and Eaton (8) which showed that the effectiveness of an immune serum was proportional to the number of parasites in the inoculum when incubated together 30 minutes at 37°C. before injection. The test used in the present study consisted of mixing 2 cc. of the immune serum with 10,000 P. knowlesi parasites, incubation at 37°C. for 30 minutes, and the injection of The mixture intra-abdominally into normal rhesus monkeys. In certain instances there was no further administration of immune serum, while in others subsequent injections were made. In order to determine the protective property of any particular serum sample, either the amount of serum or the number of parasites in the inoculum was varied.
Complement Fixation Tests.--The sera of six patients were tested for the presence and concentration of complement-fixing antibodies according to the method described by Eaton and Coggeshall (9) , in which saline extracts of concentrated P. knowlesi parasites were used for antigens.
Agglutination Tests.--Using the method of Eaton (10), attempts were made to determine the agglutinating titer of the same samples of serum used in the protection tests. The concentration of protective antibodies and agglutinins seemed to parallel each other; however, as the presence of heteroagglutinins seriously interfered with the tests even after absorption, no definite conclusions could be drawn and the data are not included.
EXPERIMENTAL
Protection Test /.--Protection tests were made on specimens of serum of patient W. F. who was inoculated intramuscularly with 2,000,000 P. knowlesl parasites, and the onset of clinical activity occurred 12 days later as evidenced by a fever of 38°C. There were six daily paroxysms, and the acute disease terminated spontaneously. The maximum temperature during this period reached 39.4°C., and the greatest number of circulating parasites was 184 per 10,000 red blood cells. Serum specimens were obtained at the time of inoculation, as well as 4 and 66 days after the acute disease had subsided. The protection tests were carried out with these specimens using 2 cc. of serum and 10,000 parasites. The specimen obtained before infection and another The results, which are summarized in Table I , show t h a t m o n k e y 1, which received the preinfection serum specimen, and m o n k e y 6, which received normal h u m a n serum, died on the 14th day and 13th day, respectively. Of the four remaining animals in which the convalescent sera were tested, m o n k e y 2 developed no infection, while monkeys 3, 4, and 5 became infected b u t survived. The 20 cc. of the 66-day serum given to m o n k e y 5 in addition to t h a t contained in the original inoculum apparently slightly diminished the intensity of the infection as compared with that of m o n k e y 4. T h e results indicate that the serum from this patient had acquired protective antibodies in demonstrable concentration in the course of the induced infection.
MALARIA ANTIBODIE~ I N HUMAN SERUM
Protection Test 2.--Protection and complement fixation tests were made on the serum specimens of patient T. H. who had been inoculated intramuscularly with 3,500,00 P. knowlesi parasites. The first sign of infection was a mild prodromal fever followed by a severe paroxysm and temperature of 40°C. on the llth day after inoculation. During the acute course of the disease which lasted 7 days there was a maximum temperature of 42°C., and the infection terminated spontaneously. The number of circulating parasites paralleled the fever curve, the greatest concentration being 306 parasitized cells per 10,000 normal red blood cells. The blood smears became negative soon after the temperature assumed a normal level and there were no relapses. A sample of serum was obtained before inoculation, at the height of the acute disease, and at 27 and 102 days after termination of the acute attack. These four specimens were tested simultaneously in individual normal monkeys for their protective effect.
The results are shown in Table II . It will be seen that no protective effect was demonstrable with specimens taken before inoculation, at the (11) where a patient after a spontaneous recovery from induced knowlesi malaria had normal temperatures and negative daily thick blood smears for 130 days, yet the blood was infectious for monkeys when subinoculated at that time.
The results of the complement fixation tests paralleled those of the protection test. The greatest concentration of complement-fixing antibodies was present in the serum that exerted the maximum protective ability.
Protection Test 3.--Protection and complement fixation tests were made on the serum specimens of patient R. G., who had been inoculated intravenously with 3,000,000 P. knowlesi parasites. An elevation of temperature occurred 3 days later and was followed by six daily paroxysms with a maximum temperature of 41.2°C. The acute disease terminated spontaneously and no relapses were noted. Serum was obtained before inoculation and 8, 28, and 56 days after clinical activity had subsided. The three specimens of serum taken from this patient during convalescence were tested in duplicate for their protective properties in six different monkeys; three received only the inoculum which consisted of 2 cc. of immune serum and 10,000 parasites while the duplicates received an identical inoculum and an additional 1 cc. daily of the same immune serum beginning the day that parasites were first detected in the blood smears. The results of these tests are shown in Table III .
It will be seen in Table III that a definite protective effect was obtained with the serum specimens obtained 8 and 28 days after the acute attack. There was no real evidence which showed that the injection of additional serum had influenced the course of the infection in the test animals. The reason for the failure of monkeys 11, 13, and 16 to become infected is not known. It was observed that the serum from this patient agglutinated normal monkey red cells in extremely high dilutions, which may offer a possible explanation. The complement fixation test, also shown in Table  III , reveals that the maximum titer of complement-fixing antibodies was obtained with the sample of serum obtained 8 days after the acute attack had subsided. The 8-day specimen also exhibited the greatest protective effect. Thus it was seen that this patient had a definite serological immune response following the attack of induced malaria.
Protection Test 4.--As the serum obtained from patient R. G. on the 8th day after the acute infection had terminated had the greatest protective ability, it was decided to test this specimen further by determining the protective antibody titer against a varying number of parasites. Accordingly the 2 cc. samples of the serum were incubated with 1,000,000, 100,000, 10,000, and 1000 parasites, respectively, and each mixture was injected into individual monkeys. One control monkey received 2 cc. of normal human serum and 10,000 parasites.
The results are shown in Table IV , and it was found t h a t the length of disease increased as the n u m b e r of parasites was decreased in the inoculum. As the a m o u n t of immune serum was kept constant, these results are taken to indicate a definite protective effect. The failure of m o n k e y 22 to survive when the dose of parasites was only 1000 does not invalidate the general result. Protection Test 5.--Serum specimens were obtained for protection and complement fixation tests on patient B. A. who was inoculated intravenously with 1 cc. of infected blood containing approximately 10,000,000 P. knowlesi parasites. Clinical activity of the infection was mild, 5 days in duration, and terminated spontaneously. The maximum parasite count was 30 per 10,000 red cells. Serum samples were taken on 5, 17, and 53 days, respectively, after the acute attack had subsided and were tested in the same manner as was the serum of Protection Test 3.
T A B L E IV

Titration of Protective Effect witk 2 Cc. Serum of Patient R. G. Taken 8 Days after Recovery from Acute Attack
T h e results shown in Table V indicate t h a t the serum of this patient, who experienced an abortive clinical attack, showed a slight protective effect. Supplementary serum injections into monkeys 25 and 29 were associated with more prolonged infections than were obtained in monkeys 24 and 28, which received no additional serum, and all of the test monkeys which became infected lived longer than the control which received normal h u m a n serum. The m a x i m u m complement fixation titer was 1:8, which is a relatively low level.
Protection Test 6.--In order to obtain specimens of serum for protection and complement fixation tests, patient T. M. was inoculated intramuscularly with 1 cc. of in-fected blood containing 3,000,000 P. knowlesi parasites. The incubation period was 23 days. The acute disease lasted only 4 days and was extremely mild, with a maximum parasite count of 3 per 10,000 red cells. The acute infection terminated spontaneously. A preinoculation serum specimen was obtained and also specimens 10 and 36 days after the patient's temperature had returned to a normal level. The serum was tested in Table VI. T h e f a c t t h a t m o n k e y 33 h a d a m i l d e r infection a n d s u r v i v e d longer t h a n m o n k e y s 31 a n d 32 is i n d i c a t i v e of a s t r o n g e r p r o t e c t i v e effect of t h e s e r u m o b t a i n e d 36 d a y s after the t e r m i n a t i o n of the a c u t e a t t a c k t h a n t h a t of the p r e i n o c u l a t i o n s a m p l e or t h e one t a k e n a t the h e i g h t of the disease. I n this i n s t a n c e the s e r u m w i t h the m a x i m u m t i t e r of c o m p l e m e n t -f i x i n g anti- Protection Test 7.--Protection and complement fixation tests were made on the serum specimens of patient L. B. The inoculation was made intravenously with 18,000,000 P. knowlesi parasites, and parasites were first noted in the blood smears 10 days later, also the day of clinical onset. The acute disease lasted 5 days and the maximum temperature was 40.8°C. Only one convalescent serum specimen was taken after the temperature had returned to a normal level. Since there was only a single postinfection sample of serum obtained 16 days after the acute attack had spontaneously subsided, its protective qualities were compared to the one taken before inoculation, and a normal monkey serum control was added. The infecting dose of parasites for the protection tests was reduced to 1000 in these tests.
T h e results in Table V I I show t h a t the incubation of 4 cc. of the patient's serum obtained before the malaria infection exerted no inhibitory effect on T h e use of an equal a m o u n t of convalescent serum and 1000 parasites resulted in a mild infection and survival when injected into m o n k e y 36. M o n k e y 37, which received 1 cc. of the same serum and 1000 parasites, had a prolonged infection and succumbed on the 14th day. T h e additional control m o n k e y 38 had a typical P. knowtesi infection and died on the 11th day. Complement fixation tests showed a substantial titer of antibodies, 1:12 in the postinfection sample of serum.
Protection Test 8.--As a check on previous experiments in which it had been noted that the sera of certain patients during convalescence had a greater protective effect than those of others, it was decided to combine the remaining portions of the stronger specimens into pool 1 and compare its inhibitory action with that of pool 2, which was a mixture of those sera showing little or no activity when used in a protection experiment. The sera from these pools were tested in the usual manner for the presence of protective antibodies, and in addition an attempt was made to determine whether or not the incubation of the serum with the inoculating dose of parasites influenced the course of the infection in the test.
The results of this experiment, summarized in Table VIII, showed that monkey 39 was able to recover from its infection with the aid of the serum from pool 1, which was the more potent of the two pools. It was also indicated that the incubation of the immune serum and the parasites was a deciding factor in the favorable outcome of the infection in monkey 39, although this cannot be given too much credit because monkey 40 de- 
DISCUSSION
That protective antibodies are found in the serum of animals following recovery from an acute attack of malaria is no longer doubted. In addition to the demonstration of the existence of these immune substances, it has been consistently pointed out that their concentration is extremely low. Actually this conclusion may be unjustified. The protection tests against some bacteria and viruses, involving the use of mice in large numbers, have reached such a high degree of refinement that the potency of the immune serum can be measured quantitatively in terms of the number of infective or lethal doses of the specific agent neutralized by a given quantity of the serum. No such test is practical in malaria. In testing an intracellular parasite such as the malaria plasmodium against its antiserum, it is apparent that a situation different from that of bacteria or viruses prevails. Presumably, the parasite in the inoculum is protected by a cell membrane which prevents an intimate contact between the organism and the immune serum. This inference has considerable basis in fact; for example, Eaton (10) has shown that an immune serum will agglutinate the malaria parasite only in the mature stage and when the red cell membrane is presumably destroyed, or at least very permeable. The same serum was ineffective against the young ring or ameboid forms of the parasite. Likewise, in unpublished studies, it has been found in this laboratory that an immune serum in vitro is more effective against an equal number of segmenting forms than against young rings, although the former multiply within a few minutes into approximately 16 times more parasites. This indicates a greater protective effect by reason of accessibility of the immune serum to the parasite. Such a situation would explain why the results of the malaria protection tests in birds and monkeys are frequently indefinite; also why so many of the earlier experiments in passive immunity were negative. The parasite may be shielded from the action of immune serum not only during its growth within the red cell, but likewise throughout its entire cycle of development. It may be held that the opportunity for union between antigen and antibody would occur at the time the parasite sporulates, but just where this phenomenon takes place in the host is not known. In all probability the parasite either rapidly invades a new red cell outside the freely circulating blood or is phagocytized by a macrophage. In intense P. knowlesi infections one may obtain more than 50 per cent of red cells infected with mature segmenting forms and find only an occasional free parasite even when the animal's blood is examined at short intervals throughout the entire period of sporulation. It seems probable that in blood smears most, if not all, of the free merozoites seen outside the red cell are the result of mechanical disruption. Furthermore, Eaton and Coggeshall (12) showed that an anti-monkey red cell serum lysed infected red cells and rendered the liberated parasites non-infectious. This indicates that the free malaria parasites within the peripheral blood stream are probably not associated with, or essential to, the natural course of infection.
Another indication that the parasite is protected from the action of an immune serum is that in chronic P. knowlesi infections one is able to find a rather constant number of circulating parasites in a serum that can be shown to possess a relatively high concentration of protective antibodies. The observations cited, as well as many others, may explain why the results of the malaria protection tests cannot be compared with those obtained in many other diseases. Therefore, it would seem more logical to assume that the protection tests with malaria immune serum as used are inadequate to demonstrate the actual titer of protective antibodies which may be present in a considerable concentration. From the same evidence it can be assumed that immunity in malaria is relatively ineffective and temporary, not because the immune substances are present in low concentration, but because they are unable to exert their maximum influence, either directly or indirectly, against the parasite.
The results of the complement fixation tests may be discussed briefly. In all instances the preinoculation samples of sera were negative, while the convalescent specimens contained varying concentrations of complement-fixing substances. There was no uniform correlation between their titer and protective action of the serum. Although there is no evidence to indicate that complement-fixing antibodies and protective antibodies are identical substances, they are both produced as a result of malaria infection.
In the preceding experiments it is to be noted that none of the patients experienced a clinical attack which persisted longer than 7 days. Also, all infections subsided without the aid of any treatment. This type of infection is commonly observed in Negroes, who have a marked resistance to P. knowlesi infections as compared with white persons. A more definite protective effect might have been obtained with immune serum taken from individuals more susceptible to this parasite. SUMM 
ARY
Evidence has been presented which indicates that antibodies appear in the serum of individuals following an induced malaria infection with Plasmodium knowlesi. 
